Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Epstein-Barr Virus Infections 3Glioblastoma 2Cytomegalovirus Infections 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Solid Tumor, Adult 1Sezary Syndrome 1Pyloric Stenosis, Hypertrophic 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Mycosis Fungoides 1Multiple Myeloma 1Multi-centric Castleman's Disease 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

pembrolizumab 4Proton Therapy 3toripalimab 1spartalizumab 1patritumab deruxtecan 1osimertinib 1mirdametinib 1leronlimab 1amivantamab 1Valganciclovir 1Radiotherapy 1Paclitaxel 1Lacteol 1Interleukin-2 1Docetaxel 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1BGB-283 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumor, Adult × Valganciclovir × 1 year × Clear all
NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

GenVivo, Inc.

Phase 1 Terminated
37 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡